AI Optics

About AI Optics

AI Optics, a medical device and digital health company, was established in 2020 by co-founders Luke Moretti and Andrew DiGiore. The venture was born from Moretti's experience at NYU Medical School, where he witnessed patients suffering from vision loss due to a lack of accessible eye screening, prompting him to leave after his third year to establish the company. Moretti, who serves as CEO, brings a background in neuroscience from Vanderbilt University and four years of medical device development experience. COO Andrew DiGiore contributes over 18 years of expertise in the medical device sector, having successfully guided multiple products from concept to launch and holding over 60 patents.

The company's core mission is to shift retinal disease screening from specialized offices to point-of-care settings, thereby increasing patient access and enabling early intervention. AI Optics addresses the significant barriers of geography, cost, and inconvenience that often prevent individuals from receiving timely screenings for conditions like diabetic retinopathy, glaucoma, and age-related macular degeneration. The business operates in the diagnostic equipment and HealthTech markets, generating revenue through the sale of its medical devices. Its primary clients include primary care clinics, health systems, private practices, home health providers, and retail health clinics.

AI Optics has developed a handheld imaging device that combines proprietary optics with artificial intelligence to screen for retinal diseases. The screening process is designed for ease of use by medical assistants and can be completed in under two minutes during a routine patient visit. The company offers the Sentinel Camera, an FDA-cleared device for capturing digital images of the human eye. Its future product, the Sentinel Pro, will integrate on-device AI software to identify and diagnose various retinal diseases. While the Sentinel Camera has received FDA clearance, the Sentinel Pro is currently intended for investigational use and is not yet FDA-cleared.